China Pharma Holdings (CPHI) Current Deferred Tax Assets (2010 - 2013)
China Pharma Holdings' (CPHI) quarterly Current Deferred Tax Assets came in at $2.2 million in Q3 2013, up 223.62% on a YoY basis from $678297.0 in Q3 2012, and up 29.88% quarter-over-quarter from $1.7 million in Q2 2013.
Analysis
China Pharma Holdings (CPHI) Current Deferred Tax Assets (2010 - 2013) Analysis & Trends
China Pharma Holdings (CPHI) has reported Current Deferred Tax Assets for 4 consecutive years, with $2.2 million the latest figure, recorded in Q3 2013.
- For the quarter ending Q3 2013, Current Deferred Tax Assets rose 223.62% year-over-year to $2.2 million; the trailing twelve-month figure through Sep 2013 stood at $2.2 million (up 223.62% YoY), and the FY2012 full-year result was $967671.0, up 70.9% from the prior year.
- Current Deferred Tax Assets advanced to $2.2 million in Q3 2013 per CPHI's latest filing, from $1.7 million in the prior quarter.
- Across five years, Current Deferred Tax Assets topped out at $2.2 million in Q3 2013 and bottomed at $518906.0 in Q3 2011.
- Historically, Current Deferred Tax Assets has averaged $899573.5 across 4 years, with a median of $653266.0 in 2012.
- The sharpest annual moves came in 2011 and 2013: Current Deferred Tax Assets increased 7.1% in 2011, then surged 223.62% in 2013.
- Over 4 years, Current Deferred Tax Assets stood at $528684.0 in 2010, then grew by 7.1% to $566226.0 in 2011, then surged by 70.9% to $967671.0 in 2012, then surged by 126.85% to $2.2 million in 2013.
- According to Business Quant data, Current Deferred Tax Assets over the past three periods registered $2.2 million, $1.7 million, and $954980.0 for Q3 2013, Q2 2013, and Q1 2013 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.26 Bn | 622.50 Bn | 17.26 Bn |
| 2 | AbbVie | 443.31 Bn | 436.74 Bn | 12.70 Bn |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn |
| 4 | Novartis Ag | 266.46 Bn | 258.77 Bn | 11.24 Bn |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn |
| 6 | Sanofi | 52.33 Bn | 44.95 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 43.79 Bn | 43.79 Bn | - |
| 8 | Incyte | 25.23 Bn | 20.69 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.67 Bn | 19.01 Bn | 683.80 Mn |
| 10 | China Pharma Holdings | 31.39 Mn | 31.08 Mn | 83,566.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2013 | 2.20 Mn |
| Jun 30, 2013 | 1.69 Mn |
| Mar 31, 2013 | 954,980.00 |
| Dec 31, 2012 | 967,671.00 |
| Sep 30, 2012 | 678,297.00 |
| Jun 30, 2012 | 653,266.00 |
| Mar 31, 2012 | 617,753.00 |
| Dec 31, 2011 | 566,226.00 |
| Sep 30, 2011 | 518,906.00 |
| Jun 30, 2011 | 524,290.00 |
| Dec 31, 2010 | 528,684.00 |